AESHA PARIKH: Open Payments
NPI 1285310334 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,383 in 162 payments from 20 companies in 2025. Trend: 2023 $1,020 · 2024 $3,178 · 2025 $3,383
Food & beverage: $3,383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $663 |
| Takeda Pharmaceuticals U.S.A., Inc. | 49 | $596 |
| Janssen Biotech, Inc. | 23 | $570 |
| GENZYME CORPORATION | 9 | $285 |
| QOL Medical, LLC | 8 | $225 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $158 |
| Ardelyx, Inc. | 8 | $135 |
| PFIZER INC. | 6 | $123 |
| Ipsen Biopharmaceuticals, Inc | 5 | $119 |
| Alnylam Pharmaceuticals Inc. | 3 | $99 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, DUPIXENT, Sucraid, EOHILIA, RINVOQ, XIFAXAN.
Industry payments across VA — which companies pay providers there.
